Scientists revive 160-million-year-old proteins to fight drug-resistant bacteria
Researchers at the University of Oregon have reconstructed 160-million-year-old proteins to develop new antimicrobial treatments. These ancient proteins show promise in combating modern drug-resistant bacteria.
Why it matters
This research offers a novel evolutionary approach to solving the growing global health crisis of antibiotic resistance.
There is an unexpected place scientists are looking for clues to the next generation of infection-fighting drugs: deep in the evolutionary past. At the University of Oregon, researchers reconstructed proteins that existed as far back as 160 million years ago and found that some of their antimicrobial fragments could outperform corresponding versions found in humans when tested against drug-resistant bacteria, states a release shared by Science Daily. The research, published in PLOS Biology on August 25, offers a glimpse into how nature refined its own defence mechanisms over millions of years and how those evolutionary experiments could potentially inform future treatments for infections that no longer respond well to conventional antibiotics.Searching the mammalian pastThe study focused on lactoferrin, an immune protein found in almost every body fluid except blood, including breast milk, tears, saliva and intestinal mucus.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in